TOX/See multi-Drugscreen Panel 10-test (AMP/BAR/BZO/COC/MET/MTD/OPI/PCP/TCA/THC)
Navigation Links
TOX/See multi-Drugscreen Panel 10-test (AMP/BAR/BZO/COC/MET/MTD/OPI/PCP/TCA/THC)
| Products | TOX/See multi-Drugscreen Panel 10-test (AMP/BAR/BZO/COC/MET/MTD/OPI/PCP/TCA/THC) |
| Company | Bio-Rad Laboratories |
| Item | TOX/See multi-Drugscreen Panel 10-test (AMP/BAR/BZO/COC/MET/MTD/OPI/PCP/TCA/THC) |
| Features |
|
| Description | TOX/See™ is a 1-step, hand-held, point-of-care device for the qualitative detection of drug or drug metabolites in human urine. The TOX/See device can detect up to nine of the most commonly abused drugs in 3 to 8 minutes and requires only a few drops of urine. Each TOX/See cassette is individually packaged to maximize convenience and ease of use. TOX/See features integrated test controls, easy-to-read results, and an 18-month shelf life at room temperature. The completed test card can be photocopied and archived for health and legal records. The straightforward test protocol is designed for use by all levels of staff in hospitals, emergency departments, correctional facilities, juvenile facilities, police departments, workplaces, and recovery and rehabilitation programs. |
| Info | Bio-Rad Laboratories Customer Service: 1-800-2-BIORAD Web site: http://www.bio-rad.com |
Related medicine products :
1. TOX/See Rapid Urine Drug Screen Tests
2. TOX/See multi-Drugscreen Panel 10-test (AMP/BAR/BZO/COC/MDMA/MET/MTD/OPI/PCP/THC)
3. TOX/See multi-Drugscreen Panel 9-test (PCP/BAR/AMP1000/COC/MET1000/TCA/MOR300/THC/BZO)
4. TOX/See multi-Drugscreen Panel 10-test (AMP/BAR/BZO/COC/MDMA/MET/MTD/OPI/TCA/THC)
5. TOX/See multi-Drugscreen Panel 8-test (AMP1000/COC/MOR300/THC/BZO/MET1000/MTD/BAR)
6. TOX/See multi-Drugscreen Panel 8-test (THC/COC/AMP1000/PCP/BAR/BZO/MOR2000/MTD)
7. TOX/See multi-Drugscreen Panel 8-test (THC/COC/AMP1000/PCP/BAR/BZO/MOR300/MTD)
8. TOX/See multi-Drugscreen Panel 5-test THC/MOR300/AMP1000/COC/BZO
9. TOX/See multi-Drugscreen Panel 5-test THC/COC/PCP/MOR300/AMP1000
10. TOX/See multi-Drugscreen Panel 5-test THC/COC/MOR300/AMP1000/MET1000
11. TOX/See multi-Drugscreen Panel 3-test AMP1000/MET1000/MDMA
Utilized for capsulotomies, nucleus dislocating, and other intraocular applications. Formed (bent) cystitomes are angled to conform to the convexity of the lens, providing easier access to the anteri
Left. 23 gauge thin wall irrigation. 25 gauge thin wall aspiration. Angled 20 degree shaft 10 mm from tip to bend. Irrigation tip set 0.5 mm behind aspiration tip. Side taper irrigation-aspiration th
This specially designed 23 gauge spoon-shaped cannula is connected to a balanced salt solution bottle and with a low-flow of fluid, is designed to allow a controlled cleaning of the stromal interface
Reliance pneumatic stools come with five legs for extra stability. Adjustable height range of 18" to 25" (total vertical travel 6"). 2" ball bearing swivel hard rubber castors. Comfortable, durable a
Medicine Products:(Date:12/3/2008)...ber 3, 2008 (BRONX, NY) A new study led by resea...eshiva University has clarified how two major vari...logic complications. The finding, published in J...or drugs that could prevent HIV-associated dementi...on in people with AIDS. Even with anti-retroviral ...
(Date:12/3/2008)...who had aggressive surgeries were free of tumor re..., , ROCHESTER, Minn., Dec. 3 /PRNewswire-USN...ients with low-grade gliomas survived longest when...ly remove the entire tumor. If safely removing the...significantly longer when surgery was followed by ...
(Date:12/3/2008)... N.J., Dec. 3 Memory Pha...ced that, on December 3, 2008, the Company,receiv...ions Panel (the,"Panel") that the Panel has deter... NASDAQ Capital Market. However, the Company was ...earing Review Council (the "Review Council") has,...
(Date:12/3/2008)...To Three and Half Times Greater Than Entire U.S. E...swire/ -- If the federal government stopped the Me...llecting no more payroll taxes and allowing no mor...$52 trillion to those who have already earned thes...al Center for Policy Analysis (NCPA). , , ...
Breaking Medicine News(10 mins):Health News:Study sheds light on causes of HIV dementia 2Health News:Study sheds light on causes of HIV dementia 3Health News:Mayo Clinic Identifies Best Treatments for Long-Term Survival in Brain Tumor Patients 2Health News:Mayo Clinic Identifies Best Treatments for Long-Term Survival in Brain Tumor Patients 3Health News:Memory Pharmaceuticals Receives NASDAQ Decisions 2Health News:Memory Pharmaceuticals Receives NASDAQ Decisions 3Health News:Medicare, Social Security Owe Up to $52 Trillion to Current Retirees and Workers 2... the Revised National TB Control Programme (RNTCP)...ized//, good quality treatment and diagnostic serv...t about 50 - 60 % of HIV-positive people are more ...n Health and Family Welfare Minister Anbumani Rama...
...o the study conducted by Steven M. Kurtz, of Expon...entific consulting firm//, there is an increase in...the number of artificial joints needed to replace ...ar by 2030. The study showed that the demand for a...
...iet and products had captured the market and minds... medical scrutiny. // A number of detox products ...This follows a report by the BBC which drew its at...cal claims. The Medical Health Care Products Regu...
...inister of Bihar, Nitish Kumar assured that the Bi...ting the alarming spread of AIDS/HIV in the state ...he Udayan Sharma foundation, Samyak and the Nation... Expressing concern over the explosive prevalence...
Other Medicine News:Health News:India to Implement National Action Plan against TB-HIV 2(Date:12/2/2008)...Ill., Dec. 2 Horizon Therapeutics,..., today announced that two pivotal,Phase 3 trials...date, HZT-501,met all primary endpoints. HZT-501...duct containing ibuprofen and famotidine, demonstr... incidence of non-steroidal,anti-inflammatory dru...
(Date:12/1/2008)...E, Md., Dec. 1 Vanda Pha...ation in The Lancet , one of the world,s leading ...s novel circadian regulator, experimental compound...tnam et al(1) is entitled "Melatonin agonist tasim...p-time shift: two randomised controlled multicentr...
(Date:12/1/2008)...l with Hypophosphatasia Treated With ENB-0040 at C...ipeg , , MONTREAL, Dec. 1 E... focused on developing novel therapeutics for seri... infant patient in its clinical program for hypoph...me Replacement Therapy (ERT) with ENB-0040 for the...
(Date:12/1/2008)...TGARD, Denmark, December 1 /PRNewswire-FirstCall/ ...7 with the intent to procure an MVA-based,third ...rnment Services,Canada, on behalf of the Canadian...ntract to Bavarian Nordic for the delivery of IMVA...to use IMVAMUNE(R) as part of the,country,s bio-p...
Breaking Medicine Technology:Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 2Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 4Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 2Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 3Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 2Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 5The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 2The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 3Highmark Blue Cross Blue Shield United Concordia and Catholic Charities Join Forces to Offer Free Health Dental Services This Saturday 24194 1Highmark Blue Cross Blue Shield United Concordia and Catholic Charities Join Forces to Offer Free Health Dental Services This Saturday 24194 2Norgen Biotek Corp Launches Four New Kits for the Purification of RNA and DNA from Plants and Fungi 6644 1Norgen Biotek Corp Launches Four New Kits for the Purification of RNA and DNA from Plants and Fungi 6644 2Alzheimers Research Brings Progress Setbacks 24192 1Alzheimers Research Brings Progress Setbacks 24192 2Alzheimers Research Brings Progress Setbacks 24192 3Alzheimers Research Brings Progress Setbacks 24192 4minSURG 28TM 29 Corporation Launches International Division 24190 1minSURG 28TM 29 Corporation Launches International Division 24190 2[0] Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints[0] Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet[0] Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease[0] The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness
...ed Statistical Significance, FRAZER, Pa., May 01.... Phase 3 clinical trial presented today at the 59...rology in Boston highlights,data demonstrating t...s beneficial for the treatment of breakthrough pai...ady taking opioids around-the,clock to manage th...
...y 1, 2007 - Genentech, Inc. (NYSE:DNA),and Biogen ...ata,from a Phase II clinical study of Rituxan(R) (...ltiple sclerosis (RRMS) were,presented today at th...d in Boston. Rituxan is a therapeutic antibody tha...-cells., "There remains a great need for safe and ...
Other Medicine Technology:Cephalon Presents Positive Results for Fentora in Breakthrough Pain,Associated with Neuropathic Conditions 2Cephalon Presents Positive Results for Fentora in Breakthrough Pain,Associated with Neuropathic Conditions 3Cephalon Presents Positive Results for Fentora in Breakthrough Pain,Associated with Neuropathic Conditions 4Cephalon Presents Positive Results for Fentora in Breakthrough Pain,Associated with Neuropathic Conditions 5Cephalon Presents Positive Results for Fentora in Breakthrough Pain,Associated with Neuropathic Conditions 6Cephalon Presents Positive Results for Fentora in Breakthrough Pain,Associated with Neuropathic Conditions 7Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple,Sclerosis Presented at the American Academy of Neurology 2Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple,Sclerosis Presented at the American Academy of Neurology 3Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple,Sclerosis Presented at the American Academy of Neurology 4Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple,Sclerosis Presented at the American Academy of Neurology 5Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple,Sclerosis Presented at the American Academy of Neurology 6| Copyright © 2003-2008 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |